Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries

Journal of the American College of Cardiology

Volumn 32, Issue 4, 1998, Pages 1109-1117

  Van Beusekom, Heleen M m ^a,b   Whelan, Deirdre M ^a,b   Hofma, Sjoerd H ^a,b   Krabbendam, Stefan C ^a,b   Van Hinsbergh, Victor W m ^a,b,c,d   Verdouw, Pieter D ^a,b   Van Der Giessen, Willem J ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c TNO   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CORONARY ARTERY DISEASE; HYPOTHESIS; LEUKOCYTE ADHERENCE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STENT; SWINE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CAPILLARY PERMEABILITY; CELL DIVISION; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; STENTS; SWINE; TUNICA INTIMA;

EID: 0032192119     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00348-9     Document Type: Article

References (38)

1. Colombo A, Ferraro M, Itoh A, et al. Results of coronary stenting for restenosis. J Am Coll Cardiol 1996 Oct;28:830-6.
2. Karrillon G.J., Morice M.C., Benveniste E., et al. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30-day clinical outcome of the French Multicenter Registry. Circulation. 94:1996;1519-1527.
3. Serruys P.W., Emanuelsson H., van der Giessen W., et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study. Circulation. 93:1996;412-422.
4. Lincoff A.M., Califf R.M., Anderson K.M., et al. Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. EPIC Investigators. Evaluation of 7E3 in preventing ischemic complications. J Am Coll Cardiol. 30:1997;149-156.
5. Shimokawa H., Flavahan N.A., Shepherd J.T., Vanhoutte P.M. Endothelium dependent inhibition of ergonovine-induced contraction is impaired in porcine coronary arteries with regenerated endothelium. Circulation. 80:1989;643-650.
6. Weidinger F.F., McLenachan J.M., Cybulsky M.I., et al. Persistent dysfunction of regenerated endothelium after PTCA of rabbit iliac artery. Circulation. 81:1990;1667-1679.
7. McLenachan J.M., Vita J., Fish D.R., et al. Early evidence of endothelial vasodilator dysfunction at coronary branchpoints. Circulation. 82:1990;1169-1173.
8. Badimon L., Badimon J., Penny W., et al. Endothelium and atherosclerosis. J Hyperten. 10:(Suppl 2):1992;43-50.
9. NIH publication 85-23, revised 1985.
10. Hårdhammar P., van Beusekom H.M.M., Emanuelsson H.U., et al. Reduction of thrombotic events with heparin-coated Palmaz-Schatz stents in pigs. Circulation. 93:1996;423-430.
11. Van der Giessen W.J., Serruys P.W., Van Beusekom H.M.M., et al. Coronary stenting with a new, radiopaque, balloon expandable endoprosthesis in pigs. Circulation. 83:1991;1788-1798.
12. Björkerud S., Bondjers G. Endothelial integrity and viability in the aorta of the normal rabbit and rat as evaluated with dye exclusion tests and interference contrast microscopy. Atherosclerosis. 15:1972;285-300.
13. Caplan B.A., Schwartz C.J. Increased endothelial cell turnover in areas of in vivo evans blue uptake in pig aorta. Atherosclerosis. 17:1973;401-417.
14. Van Beusekom H.M.M., van der Giessen W.J., Wagenvoort C.A., et al. Histological features of a polymer endovascular prosthesis after transcatheter implantation in porcine arteries. Cardiovascular Pathology. 2:1993;41-52.
15. Hofma S.H., Whelan M.C., van Beusekom H.M.M., Verdouw P.D., van der Giessen W.J. Increasing arterial wall injury after long term implantation of two stent types in a porcine coronary model. Eur Heart J. 19:1998;601-609.
16. Post M.J., Borst C., Kuntz R.E. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after PTCA a study in the normal rabbit and the hypercholesterolemic Yucatan micropig . Circulation. 89:1994;2816-2822.
17. Mintz G.S., Pichard A.D., Kent K.M., et al. Intravascular ultrasound comparison of restenotic and de novo coronary artery narrowings. Am J Cardiol. 74:1994;1278-1280.
18. Ross R. The pathogenesis of atherosclerosis. An update. N Engl J Med. 314:1986;488-500.
19. Van Beusekom H.M.M., Van der Giessen W.J., Van Suylen R.J., et al. Histology after stenting of human saphenous vein bypass grafts Observations from surgically excised grafts 3 to 320 days after stent implantation . J Am Coll Cardiol. 21:1993;45-54.
20. Rippe B., Haraldsson B. Transport of macromolecules across microvascular walls the two pore theory . Physiol Rev. 74:1994;163-219.
21. Michel C.C. Transport of macromolecules through microvascular walls. Cardiovasc Res. 32:1996;644-653.
22. Palade G.E. The microvascular endothelium revisited. Simionescu N., Simionescu M. Endothelial Cell Biology in Health and Disease. 1988;3-21 Plenum Publishing Corp, New York.
23. Baluk P., McDonald D.M. The B2-adrenergic receptor agonist formoterol reduces microvascular leakage by inhibiting endothelial gap formation. Am J Physiol. 1994;L461-L468.
24. Van Hinsbergh V.W.M. Endothelial permeability for macromolecules. Mechanistic aspects of pathophysiological modulation. Arterioscl Thromb Vasc Biol. 17:1997;1018-1023.
25. Lum H., Malik A.B. Regulation of vascular endothelial barrier function. Lung Cell Mol Physiol. 11:1994;L223-L241.
26. Drenckhahn D., Ness W. The endothelial contractile cytoskeleton. Born G.V.R., Schwartz C.J. Vascular Endothelium. Physiology, Pathology and Therapeutic Opportunities. 1997;1-25 Schattauer, Stuttgart.
27. Garcia J.G.N., Davis H.W., Patterson C.E. Regulation of endothelial cell gap formation and barrier dysfunction role of myosin light chain phosphorylation . J Cell Physiol. 163:1995;510-522.
28. Granger D.N., Korthuis R.J. Physiological mechanisms of postischemic tissue injury. Ann Rev Physiol. 57:1995;311-332.
29. Lin S.J., Jan K.M., Weinbaum S., Chien S. Transendothelial transport of low density lipoprotein in association with cell mitosis in rat aorta. Arteriosclerosis. 9:1989;230-236.
30. Meredith J.E., Faxeli B., Schwartz M.A. The extracellular matrix as a cell survival factor. Mol Biol Cell. 4:1993;953-961.
31. Roberts W.G., Palade G.E. Increase microvascular permeability and endothelial fenestrations induced by vascular endothelial growth factor. J Cell Sci. 108:1995;2369-2379.
32. Lindner V., Reidy M.A. Expression of VEGF receptors in arteries after endothelial injury and lack of increased endothelial regrowth in response to VEGF. Arterioscler Throm Vasc Biol. 16:1996;1399-1405.
33. Tsurumi Y., Murohara T., Krasinski K., et al. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nature Medicine. 3:1997;879-886.
34. Rippe B., Grega G.J. Effects of isoprenaline and cooling on histamine induced changes of capillary permeability in the rat hindquarter vascular bed. Acta Physiol Scand. 103:1978;252-262.
35. Stelzner T.J., Weil J.V., O'Brien R.F. Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties. J Cell Physiol. 139:1989;157-166.
36. Langeler E.G., van Hinsbergh V.W.M. Norepinephrine and iloprost improve barrier function of human endothelial cell monolayers role of cAMP . Am J Physiol. 260:1991;C1052-C1059.
37. Tertov V.V., Orekhov A.N., Grogorian G., et al. Disorders in the system of cyclic nucleotides in atherosclerosis cyclic AMP and cyclic GMP content and activity of related enzymes in human aorta . Tissue Cell. 19:1987;21-28.
38. Page M., Ashhurst D.E. The effects of mechanical stability on the macromolecules of the connective tissue matrices produced during fracture healing. II. The glycosaminoglycans. Histochem J. 19:1987;39-61.